Genetically engineered mouse models with somatic deletion of TP53 and Rb1 in lung are able to recapitulate many clinical manifestations of ASCL1High SCLC, including the extrapulmonary metastases34,35. The gene discussed is TP53; the disease is small cell lung carcinoma.